Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation

New England Journal of Medicine

Volumn 345, Issue 19, 2001, Pages 1378-1387

  Bartelink, Harry ^a   Horiot, Jean Claude ^f   Poortmans, Philip ^b   Struikmans, Henk ^c   Van Den Bogaert, Walter ^h   Barillot, Isabelle ^f   Fourquet, Alain ^g   Borger, Jacques ^a   Jager, Jos ^d   Hoogenraad, Willem ^e   Collette, Laurence ⁱ   Pierart, Marianne ⁱ  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MAASTRO CLINIC   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f CENTRE GEORGES FRANÇOIS LECLERC   (France)

^g INSTITUT CURIE   (France)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ EORTC DATA CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRON BEAM; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; STATISTICAL ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; QUALITY ASSURANCE, HEALTH CARE; SALVAGE THERAPY; SURVIVAL ANALYSIS;

EID: 0035829843     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa010874     Document Type: Article

References (35)

1. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer
2. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of lifetable analysis
3. Breast conservation is a safe method in patients with small cancer of the breast: Long-term results of three randomised trials on 1,973 patients
4. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
5. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial
6. Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials
7. Randomised controlled trial of conservation therapy for breast cancer: 6-Year analysis of the Scottish trial
8. Radiotherapy after breastpreserving surgery in women with localized cancer of the breast
9. Sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial
10. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for nodenegative breast cancer: An update
11. TNM clinical classification
12. Quality assurance in conservative treatment of early breast cancer: Report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology)
13. Quality assurance of the EORTC trial 22881/10882: "Assessment of the role of the booster dose in breast conserving therapy": The Dummy Run
14. Entrance and exit TL-dosimetry in the conservative treatment of breast cancer: A pilot study for the EORTC-Radiotherapy Cooperative Group
15. In vivo dosimetry during tangential breast treatment
16. Quality assurance of EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": The individual case review
17. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
18. Nonparametric estimation from incomplete observations
19. The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial
20. The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC "boost vs no boost" trial
21. Breast radiotherapy after breast-conserving surgery
22. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France
23. Age as prognostic factor in premenopausal breast carcinoma
24. Breast cancer outcome and predictors of outcome: Are there age differentials?
25. Risk factors in breast-conservation therapy
26. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials
27. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study
28. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy
29. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
30. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer
31. Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma
32. Side effects of adjuvant treatment of breast cancer
33. Quality of life of earlystage breast cancer patients treated with radical mastectomy or breast-conserving procedures: Results of EORTC Trial 10801